These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29380036)

  • 21. Impact of TYMS gene polymorphism on the outcome of methotrexate treatment in a sample of Iraqi rheumatoid arthritis patients - identification of novel single nucleotide polymorphism: Cross-sectional study.
    Mutlak QM; Kasim AA; Aljanabi AS
    Medicine (Baltimore); 2024 Jun; 103(23):e38448. PubMed ID: 38847705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis patients?
    Ghodke Y; Chopra A; Joshi K; Patwardhan B
    Clin Rheumatol; 2008 Jun; 27(6):787-9. PubMed ID: 18274813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis : A meta-analysis.
    Lee YH; Bae SC; Song GG
    Z Rheumatol; 2016 Sep; 75(7):707-15. PubMed ID: 26184955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The C677T polymorphism in the MTHFR gene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population.
    Cáliz R; del Amo J; Balsa A; Blanco F; Silva L; Sanmarti R; Martínez FG; Collado MD; Ramirez Mdel C; Tejedor D; Artieda M; Pascual-Salcedo D; Oreiro N; Andreu JL; Graell E; Simon L; Martínez A; Mulero J
    Scand J Rheumatol; 2012 Feb; 41(1):10-4. PubMed ID: 22044028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
    James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
    J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate: Implications of pharmacogenetics in the treatment of patients with Rheumatoid Arthritis.
    Torres RP; Santos FP; Branco JC
    ARP Rheumatol; 2022 Oct; 1(3):225-229. PubMed ID: 35724450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia.
    Erčulj N; Kotnik BF; Debeljak M; Jazbec J; Dolžan V
    Leuk Lymphoma; 2012 Jun; 53(6):1096-104. PubMed ID: 22074251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of thymidylate synthase polymorphisms on toxicities associated with high-dose methotrexate in childhood acute lymphoblastic leukemia.
    Al-Sheikh A; Yousef AM; Alshamaseen D; Farhad R
    Cancer Chemother Pharmacol; 2021 Mar; 87(3):379-385. PubMed ID: 33170323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis.
    Fan H; Li Y; Zhang L; Li Y; Li W
    Int J Rheum Dis; 2017 May; 20(5):526-540. PubMed ID: 28544525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy.
    Lecomte T; Ferraz JM; Zinzindohoué F; Loriot MA; Tregouet DA; Landi B; Berger A; Cugnenc PH; Jian R; Beaune P; Laurent-Puig P
    Clin Cancer Res; 2004 Sep; 10(17):5880-8. PubMed ID: 15355920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients.
    Samara SA; Irshaid YM; Mustafa KN
    Int J Clin Pharmacol Ther; 2014 Sep; 52(9):746-55. PubMed ID: 25074866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
    Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
    Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of thymidylate synthase polymorphisms with the tumor response to preoperative chemoradiotherapy in rectal cancer: a systematic review and meta-analysis.
    Yang YC; Wu GC; Jin L; Wang KL; Bai ZG; Wang J; Zhang ZT
    Pharmacogenomics J; 2017 Jun; 17(3):265-273. PubMed ID: 27001118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of RFC1 c.80A>G Polymorphism on Methotrexate-Mediated Toxicity and Therapeutic Efficacy in Rheumatoid Arthritis: A Meta-analysis.
    Naushad SM; Alrokayan SA; Almajhdi FN; Hussain T
    Ann Pharmacother; 2021 Dec; 55(12):1429-1438. PubMed ID: 33749319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2R of thymidylate synthase 5'-untranslated enhanced region contributes to gastric cancer risk: a meta-analysis.
    Yang Z; Liu HX; Zhang XF
    Asian Pac J Cancer Prev; 2012; 13(5):1923-7. PubMed ID: 22901148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis.
    Jenko B; Lusa L; Tomsic M; Praprotnik S; Dolzan V
    Pharmacogenomics J; 2017 Oct; 17(5):412-418. PubMed ID: 27217051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of association between CXCL9 and CXCL10 gene polymorphisms and the outcome of rheumatoid arthritis treatment with methotrexate.
    Kotrych D; Dziedziejko V; Safranow K; Pawlik A
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3037-40. PubMed ID: 26367725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.
    Qiu Q; Huang J; Lin Y; Shu X; Fan H; Tu Z; Zhou Y; Xiao C
    Medicine (Baltimore); 2017 Mar; 96(11):e6337. PubMed ID: 28296761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TYMS 2R3R polymorphism and DPYD [IVS]14+1G>A gene mutation in Mexican colorectal cancer patients.
    Gallegos-Arreola MP; Zúñiga-González GM; Sánchez-López JY; Cruz AYN; Peralta-Leal V; Figuera LE; Puebla-Pérez AM; Ronquillo-Carreón CA; Puebla-Mora AG
    Acta Biochim Pol; 2018; 65(2):227-234. PubMed ID: 29906295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
    Qiu Q; Huang J; Shu X; Fan H; Zhou Y; Xiao C
    Sci Rep; 2017 Mar; 7():44015. PubMed ID: 28266606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.